These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34208928)

  • 1. Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M
    Mangiavacchi F; Botwina P; Menichetti E; Bagnoli L; Rosati O; Marini F; Fonseca SF; Abenante L; Alves D; Dabrowska A; Kula-Pacurar A; Ortega-Alarcon D; Jimenez-Alesanco A; Ceballos-Laita L; Vega S; Rizzuti B; Abian O; Lenardão EJ; Velazquez-Campoy A; Pyrc K; Sancineto L; Santi C
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
    Cui J; Jia J
    Eur J Med Chem; 2021 Dec; 225():113789. PubMed ID: 34438124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.
    Awoonor-Williams E; Abu-Saleh AAA
    Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals.
    Sun LY; Chen C; Su J; Li JQ; Jiang Z; Gao H; Chigan JZ; Ding HH; Zhai L; Yang KW
    Bioorg Chem; 2021 Jul; 112():104889. PubMed ID: 33915460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.
    Gupta Y; Kumar S; Zak SE; Jones KA; Upadhyay C; Sharma N; Azizi SA; Kathayat RS; Poonam ; Herbert AS; Durvasula R; Dickinson BC; Dye JM; Rathi B; Kempaiah P
    Bioorg Med Chem; 2021 Oct; 47():116393. PubMed ID: 34509862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
    Verma AK; Aggarwal R
    Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of M
    Altomare A; Baron G; Cambiaghi G; Ferrario G; Zoanni B; Della Vedova L; Fumagalli GM; D'Alessandro S; Parapini S; Vittorio S; Vistoli G; Riso P; Carini M; Delbue S; Aldini G
    Molecules; 2024 Jun; 29(11):. PubMed ID: 38893578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity.
    Weng YL; Naik SR; Dingelstad N; Lugo MR; Kalyaanamoorthy S; Ganesan A
    Sci Rep; 2021 Apr; 11(1):7429. PubMed ID: 33795718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M
    Ibrahim MAA; Abdelrahman AHM; Mohamed TA; Atia MAM; Al-Hammady MAM; Abdeljawaad KAA; Elkady EM; Moustafa MF; Alrumaihi F; Allemailem KS; El-Seedi HR; Paré PW; Efferth T; Hegazy MF
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis.
    Xiao T; Wei Y; Cui M; Li X; Ruan H; Zhang L; Bao J; Ren S; Gao D; Wang M; Sun R; Li M; Lin J; Li D; Yang C; Zhou H
    Phytomedicine; 2021 Oct; 91():153704. PubMed ID: 34419736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico Studies on the Interaction between Mpro and PLpro From SARS-CoV-2 and Ebselen, its Metabolites and Derivatives.
    Nogara PA; Omage FB; Bolzan GR; Delgado CP; Aschner M; Orian L; Teixeira Rocha JB
    Mol Inform; 2021 Aug; 40(8):e2100028. PubMed ID: 34018687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases.
    Sivakumar D; Stein M
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34071582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc
    Panchariya L; Khan WA; Kuila S; Sonkar K; Sahoo S; Ghoshal A; Kumar A; Verma DK; Hasan A; Khan MA; Jain N; Mohapatra AK; Das S; Thakur JK; Maiti S; Nanda RK; Halder R; Sunil S; Arockiasamy A
    Chem Commun (Camb); 2021 Sep; 57(78):10083-10086. PubMed ID: 34514483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives.
    Amporndanai K; Meng X; Shang W; Jin Z; Rogers M; Zhao Y; Rao Z; Liu ZJ; Yang H; Zhang L; O'Neill PM; Samar Hasnain S
    Nat Commun; 2021 May; 12(1):3061. PubMed ID: 34031399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory Activity of Flavonoid Scaffolds on SARS-CoV-2 3CL
    Khamto N; Utama K; Boontawee P; Janthong A; Tatieng S; Arthan S; Choommongkol V; Sangthong P; Yenjai C; Suree N; Meepowpan P
    J Chem Inf Model; 2024 Feb; 64(3):874-891. PubMed ID: 38277124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Se-S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study.
    Parise A; Romeo I; Russo N; Marino T
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.